Read the receipt.
- Displayed amount
- $74.67 /mo equivalent
- Delivery route
- Injection
- Product status
- Compounded prescription
- Membership in this figure
- See provider inclusions and terms
- Quantity
- Confirm the exact supplied quantity
- Upfront commitment
- $224 paid upfront for 3 months
Published package includes care, medication, supplies and shipping.
Sources: OrderlyMeds — full pricing, FDA — compounding questions and answers
What this price means.
The exact three-month total is more useful than the rounded monthly headline. Dividing $224 by three produces $74.67 per month. This is a prepaid introductory period, so it is excluded from recurring-price comparisons. A fourth month should be budgeted using the regular plan, subject to the actual agreement.
Sources: OrderlyMeds — full pricing, FDA — compounding questions and answers
The product context.
Wegovy is an FDA-approved semaglutide medicine with formulation-specific labeling. Compounded semaglutide is not FDA-approved and is not a generic version of Wegovy. A provider’s starting price may apply to a particular strength or commitment. None of the prices here establishes that a preparation is appropriate or legally available for a particular patient.
Sources: Wegovy — prescribing information, FDA — compounding questions and answers, FDA — concerns with unapproved GLP-1 drugs
Before you pay.
What will actually be charged today?
$224 paid upfront for 3 months. Request the full amount due today, its supply period, the next charge date and the renewal amount. The displayed price is a sourced offer, not a personalized invoice.
Is this a clinical recommendation?
No. This review covers public product and price information. Eligibility, treatment choice and the prescribed amount require an appropriate clinician. We have not tested this product.
What should I compare it with?
Start with the same ingredient, route, supplied quantity and billing term. Add any separate care or membership fees. Differences in product approval or formulation remain meaningful even when prices are similar.
Follow the evidence
Sources & price notes
Each source retains its own check date. Provider pages document advertised terms; they do not independently establish clinical outcomes.
- OrderlyMeds — full pricing ↗
Official public information; price and terms checked October 8, 2026.
Checked October 8, 2026
- FDA — compounding questions and answers ↗
Clinical and regulatory context. A compounded preparation is not FDA-approved.
Checked October 8, 2026
- Wegovy — prescribing information ↗
Formulation-specific approved uses, contraindications and warnings.
Checked October 8, 2026
- FDA — concerns with unapproved GLP-1 drugs ↗
Safety, dosing errors, salt forms and misleading online marketing. Regulatory page rechecked October 9, 2026; retain distinctions between approval, risk information and compounding nominations.
Checked October 9, 2026